Código QR (código de barras bidimensional)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type <i>Streptococcus pneumoniae</i>

Controversy exists regarding the clinical effectiveness of the 23-valent pneumococcal polysaccharide vaccine (PPSV23) for the prevention of serotype-specific community-acquired pneumonia (CAP). The objective of this study was to define the effectiveness of PPSV23 for the prevention of CAP hospitaliz...

תיאור מלא

שמור ב:
Principais autores: Thomas Chandler, Stephen Furmanek, Ruth Carrico, Dawn Balcom, Forest Arnold, Julio Ramirez
פורמט: Artigo
שפה:Inglês
יצא לאור: MDPI AG 2022-03-01
סדרה:Microorganisms
נושאים:
community-acquired pneumonia
pneumococcal pneumonia
pneumococcal vaccine
polysaccharide vaccine
גישה מקוונת:https://www.mdpi.com/2076-2607/10/3/560
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים